Mark Charest

Mark G. Charest, Ph.D. is a founding partner of LifeSci Fund Management, LLC and is portfolio manager for the AlphaCentric LifeSci Healthcare Fund. He is an inventor on 8 drug patents and has more than a decade of healthcare investing experience at several specialized $1B+ AUM healthcare technology funds. Mark was a Kauffman Fellow at Panorama Capital where he served on the board of directors of Itero Biopharmaceuticals and was a board observer at Presidio Pharmaceuticals and PowerVision. Prior to his investment career, Mark held an operating role in the oncology area as a Medicinal Chemistry Lab Manager at the Novartis Institutes for BioMedical Research. Mark earned his Ph.D. in chemistry and chemical biology from Harvard University as a National Science Foundation Graduate Research Fellow, his MS in chemistry and chemical biology from Harvard University, and his BA in chemistry, with Highest Honors, from Rutgers University.